[
    [
        {
            "time": "",
            "original_text": "复星医药：复宏汉霖就BRAF V600E抑制剂与润新生物签订许可协议",
            "features": {
                "keywords": [
                    "复星医药",
                    "复宏汉霖",
                    "BRAF V600E抑制剂",
                    "润新生物",
                    "许可协议"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "复星医药：复宏汉霖就BRAF V600E抑制剂与润新生物签订许可协议",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "「财富周评榜」“医茅们”表现分化：迈瑞医疗市值涨304亿，“女人的茅台”爱美客周跌超13%",
            "features": {
                "keywords": [
                    "财富周评榜",
                    "医茅",
                    "迈瑞医疗",
                    "市值涨",
                    "爱美客",
                    "周跌"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "消费"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "「财富周评榜」“医茅们”表现分化：迈瑞医疗市值涨304亿，“女人的茅台”爱美客周跌超13%",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "科创板蓄势待发，中国生物制药2020处于业绩过渡期",
            "features": {
                "keywords": [
                    "科创板",
                    "中国生物制药",
                    "业绩过渡期"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "科创板蓄势待发，中国生物制药2020处于业绩过渡期",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        }
    ]
]